| Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ... Annals of neurology 69 (2), 292-302, 2011 | 11212 | 2011 |
| Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ... The Lancet Neurology 17 (2), 162-173, 2018 | 7607 | 2018 |
| Defining the clinical course of multiple sclerosis: the 2013 revisions FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ... Neurology 83 (3), 278-286, 2014 | 4017 | 2014 |
| B-cell depletion with rituximab in relapsing–remitting multiple sclerosis SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ... New England Journal of Medicine 358 (7), 676-688, 2008 | 2826 | 2008 |
| Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double‐blind placebo‐controlled multicenter trial K Hawker, P O'Connor, MS Freedman, PA Calabresi, J Antel, J Simon, ... Annals of neurology 66 (4), 460-471, 2009 | 1089 | 2009 |
| A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ... Neurology 73 (22), 1914-1922, 2009 | 781 | 2009 |
| Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome DT Okuda, EM Mowry, A Beheshtian, E Waubant, SE Baranzini, ... Neurology 72 (9), 800-805, 2009 | 776 | 2009 |
| An open label study of the effects of rituximab in neuromyelitis optica BAC Cree, S Lamb, K Morgan, A Chen, E Waubant, C Genain Neurology 64 (7), 1270-1272, 2005 | 766 | 2005 |
| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 651 | 2015 |
| T cell gelatinases mediate basement membrane transmigration in vitro. D Leppert, E Waubant, R Galardy, NW Bunnett, SL Hauser Journal of immunology (Baltimore, Md.: 1950) 154 (9), 4379-4389, 1995 | 639 | 1995 |
| Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS? A Bar‐Or, L Fawaz, B Fan, PJ Darlington, A Rieger, C Ghorayeb, ... Annals of neurology 67 (4), 452-461, 2010 | 619 | 2010 |
| Rituximab in relapsing‐remitting multiple sclerosis: a 72‐week, open‐label, phase I trial A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ... Annals of neurology 63 (3), 395-400, 2008 | 612 | 2008 |
| Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis SE Baranzini, J Wang, RA Gibson, N Galwey, Y Naegelin, F Barkhof, ... Human molecular genetics 18 (4), 767-778, 2009 | 587 | 2009 |
| The gut microbiome in human neurological disease: a review H Tremlett, KC Bauer, S Appel‐Cresswell, BB Finlay, E Waubant Annals of neurology 81 (3), 369-382, 2017 | 544 | 2017 |
| Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis EM Mowry, LB Krupp, M Milazzo, D Chabas, JB Strober, AL Belman, ... Annals of neurology 67 (5), 618-624, 2010 | 455 | 2010 |
| Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study B Banwell, L Krupp, J Kennedy, R Tellier, S Tenembaum, J Ness, ... The Lancet Neurology 6 (9), 773-781, 2007 | 430 | 2007 |
| Gut microbiota in multiple sclerosis: possible influence of immunomodulators BL Cantarel, E Waubant, C Chehoud, J Kuczynski, TZ DeSantis, ... Journal of Investigative Medicine 63 (5), 729-734, 2015 | 415 | 2015 |
| Myelin-oligodendrocyte glycoprotein antibody-associated disease R Marignier, Y Hacohen, A Cobo-Calvo, AK Pröbstel, O Aktas, ... The Lancet Neurology 20 (9), 762-772, 2021 | 400 | 2021 |
| Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study B Stankoff, E Waubant, C Confavreux, G Edan, M Debouverie, ... Neurology 64 (7), 1139-1143, 2005 | 384* | 2005 |
| Interferon beta‐1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis D Leppert, E Waubant, MR Bürk, JR Oksenberg, SL Hauser Annals of Neurology: Official Journal of the American Neurological …, 1996 | 384 | 1996 |
